Press Release

North Highland Recognized in Gartner® Hype Cycle™ for Program and Portfolio Management

Written by North Highland | Sep 11, 2025 12:00:00 PM

ATLANTA Sept. 11, 2025  North Highland, the leading change and transformation consultancy, has been named as a Sample Vendor in the 2025 Gartner® Hype Cycle™ for Program and Portfolio Management in the category of Strategic Portfolio Management Technologies. (Accessible to Gartner subscribers only)

Strategic Portfolio Management Technologies, as defined by Gartner, “are an emerging segment of the PPM software market. SPM technologies maintain an integrated portfolio model for portfolio decision-making, tracking and monitoring. They ensure portfolio alignment across strategy, execution and outcome attainment while adapting to dynamic conditions. SPM technologies are essential for business, strategy, IT and portfolio leaders participating in SPM practices to pursue strategic business outcomes.”

“We believe North Highland’s recognition in this report highlights our continued excellence in SPM technologies through our proprietary NH360 platform and our ability to deliver innovative solutions that drive meaningful transformation for our clients,” says Catalin Olteanu, North Highland senior managing director and head of Product.

Gartner, Hype Cycle for Program and Portfolio Management 2025, By Robert Handler and Woojin Choi, July 1, 2025.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.